S2 Therapeutics, Inc.
S2 Therapeutics is a specialty pharmaceutical organization headquartered in Bristol, TN. S2 is the capital and commercialization partner for Cycloset and is holder of the exclusive global license for the manufacturing, marketing and distribution of Cycloset.
S2 seeks opportunities in the pharmaceutical industry through in-licensing arrangements, acquisitions of novel branded prescription pharmaceutical products, and investing in development compounds and companies.
Valeant, Inc. holds exclusive rights to manufacture and commercialize Cycloset in the U.S.